Are Psychedelics Approaching a Mainstream Role in Psychiatry?

This event tracks the debate over whether psychedelic-assisted therapies are moving from experimental fringe toward mainstream psychiatric practice. The question was put to a panel of experts on 23 October 2026, examining the state of the field: what the evidence currently supports, where clinical development stands, and what barriers — regulatory, clinical, or practical — still separate these compounds from routine use in mental health care. The discussion is framed as an open one, with the case for a psychedelic renaissance in psychiatry presented as a proposition to be weighed rather than a settled conclusion. For clinicians and researchers, the open questions include which patient populations might benefit, what trial evidence remains outstanding, and how psychiatry would absorb these treatments if they arrive.

Written by a model from the reports · updated 2 hours ago